Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein.
暂无分享,去创建一个
P. D. De Deyn | B. Eggen | M. Mari | F. Reggiori | E. Boddeke | D. Van Dam | Zhuoran Yin | Xingdong Zhou | Femke Valkenburg | B. Hornix | I. Mantingh-Otter | P. D. de Deyn
[1] Chi Li,et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[2] Y Ben-Shlomo,et al. Clinical features and natural history of progressive supranuclear palsy , 2003, Neurology.
[3] S. Rotshenker. The Role of Galectin-3/MAC-2 in the Activation of the Innate-Immune Function of Phagocytosis in Microglia in Injury and Disease , 2009, Journal of Molecular Neuroscience.
[4] Ann Saada,et al. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2 , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[5] I. Reynolds,et al. Mitochondrial Trafficking to Synapses in Cultured Primary Cortical Neurons , 2006, The Journal of Neuroscience.
[6] D. Prvulovic,et al. Treatment Options for Tauopathies , 2012, Current Treatment Options in Neurology.
[7] J. Brion,et al. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1 , 2004, Neurobiology of Disease.
[8] R. D'Hooge,et al. Increased gait variability in mice with small cerebellar cortex lesions and normal rotarod performance , 2013, Behavioural Brain Research.
[9] R. Hauser,et al. Diffuse lewy body disease , 2001, Current treatment options in neurology.
[10] J. Trojanowski,et al. P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating , 2011, PloS one.
[11] Kai Zhang,et al. Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.
[12] B. Sommer,et al. Expression of APP in transgenic mice: a Comparison of neuron-specific promoters , 1996, Neurobiology of Aging.
[13] John Q Trojanowski,et al. Transgenic animal models of tauopathies. , 2005, Biochimica et biophysica acta.
[14] S. Brady,et al. Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[15] Hirotaka Yoshida,et al. Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein , 2002, The Journal of Neuroscience.
[16] S. Chandran,et al. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. , 2008, Brain : a journal of neurology.
[17] L. Tönges,et al. Axonal degeneration as a therapeutic target in the CNS , 2012, Cell and Tissue Research.
[18] Mark Ellisman,et al. Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma , 2011, Proceedings of the National Academy of Sciences.
[19] E. Mandelkow,et al. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses , 2003, Neurobiology of Aging.
[20] J. Brandt,et al. Motor signs during the course of Alzheimer disease , 2004, Neurology.
[21] L. Roth,et al. Impaired gait pattern as a sensitive tool to assess hypoxic brain damage in a novel mouse model of atherosclerotic plaque rupture , 2015, Physiology & Behavior.
[22] M. Schliwa,et al. Structural interaction of cytoskeletal components , 1981, The Journal of cell biology.
[23] E. Melamed,et al. The “Dying-Back” Phenomenon of Motor Neurons in ALS , 2011, Journal of Molecular Neuroscience.
[24] S. Kato,et al. Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy , 2012, Neurobiology of Aging.
[25] Zhihua Feng,et al. Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. , 2012, Human molecular genetics.
[26] J. Paul Bolam,et al. Extrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis , 2016, Front. Neuroanat..
[27] L. Poncelet,et al. Motor deficit in a tauopathy model is induced by disturbances of axonal transport leading to dying-back degeneration and denervation of neuromuscular junctions. , 2015, The American journal of pathology.
[28] A. Bush,et al. Motor and cognitive deficits in aged tau knockout mice in two background strains , 2014, Molecular Neurodegeneration.
[29] I. Grundke‐Iqbal,et al. Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.
[30] Luigi Ferrucci,et al. The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle , 2014, Front. Aging Neurosci..
[31] M. Raaben,et al. Mouse Hepatitis Coronavirus RNA Replication Depends on GBF1-Mediated ARF1 Activation , 2008, PLoS pathogens.
[32] Jian-Wei Zhu,et al. Toll-Like Receptor 4 Deficiency Impairs Motor Coordination , 2016, Front. Neurosci..
[33] G. Bennett,et al. Terminal arbor degeneration – a novel lesion produced by the antineoplastic agent paclitaxel , 2011, The European journal of neuroscience.
[34] E. Mandelkow,et al. Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis* , 2004, Journal of Biological Chemistry.
[35] P. Reddy,et al. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease , 2011, Brain Research.
[36] D. Westaway,et al. Microglial activation in brain lesions with tau deposits: Comparison of human tauopathies and tau transgenic mice TgTauP301L , 2008, Brain Research.
[37] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[38] Bin Zhang,et al. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.
[39] F. de Winter,et al. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease , 2014, Front. Neurosci..
[40] F. van Leuven,et al. Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* , 2005, Journal of Biological Chemistry.
[41] Bin Zhang,et al. Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.
[42] U. Rutishauser,et al. Adherens Junctions in Myelinating Schwann Cells Stabilize Schmidt-Lanterman Incisures via Recruitment of p120 Catenin to E-Cadherin , 2005, The Journal of Neuroscience.
[43] Sylvie M. de Waegh,et al. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] K. Ashe,et al. Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.
[45] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[46] S H Ferris,et al. Motor/Psychomotor Dysfunction in Normal Aging, Mild Cognitive Decline, and Early Alzheimer's Disease: Diagnostic and Differential Diagnostic Features , 1997, International Psychogeriatrics.
[47] Hui Zheng,et al. In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease , 2007, NeuroImage.
[48] D. Raj,et al. Priming of microglia in a DNA-repair deficient model of accelerated aging , 2014, Neurobiology of Aging.
[49] E. Alleva,et al. Early behavioural markers of disease in P301S tau transgenic mice , 2010, Behavioural Brain Research.
[50] E. Mandelkow,et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.
[51] Matthias Endres,et al. Assessing Post-Stroke Behavior in Mouse Models of Focal Ischemia , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[52] L. Buée,et al. P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.
[53] V. Melis,et al. Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer’s disease and frontotemporal lobar degeneration , 2014, Cellular and Molecular Life Sciences.
[54] Antonia Gutierrez,et al. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus , 2011, Acta Neuropathologica.
[55] D. Williams,et al. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tau , 2006, Internal medicine journal.
[56] N. Sousa,et al. Absence of Tau triggers age‐dependent sciatic nerve morphofunctional deficits and motor impairment , 2016, Aging cell.
[57] G. Shelton,et al. Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy , 1998, Acta Neuropathologica.
[58] H. Geerts,et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.
[59] U. Frey,et al. Endogenous Serine Protease Inhibitor Modulates Epileptic Activity and Hippocampal Long-Term Potentiation , 1997, The Journal of Neuroscience.
[60] M. Spillantini,et al. Tau gene mutations: dissecting the pathogenesis of FTDP-17. , 2002, Trends in molecular medicine.
[61] A. Vercelli,et al. Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy , 2016, Front. Neuroanat..
[62] J. Trojanowski,et al. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.
[63] J. Gal,et al. Mitochondrial dysfunction in amyotrophic lateral sclerosis. , 2010, Biochimica et biophysica acta.
[64] J. Silver,et al. The role of astrocytes in axon guidance during development and repair , 1997 .
[65] John P. John,et al. Assessing Neurocognition via Gamified Experimental Logic: A Novel Approach to Simultaneous Acquisition of Multiple ERPs , 2016, Front. Neurosci..
[66] S. Dunnett,et al. Tests to assess motor phenotype in mice: a user's guide , 2009, Nature Reviews Neuroscience.
[67] D. Wilcock,et al. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.
[68] S. Lisney,et al. Regeneration of unmyelinated axons after injury of mammalian peripheral nerve. , 1989, Quarterly journal of experimental physiology.
[69] Sameer B. Shah,et al. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles , 2013, The Journal of physiology.
[70] R. Mirsky,et al. The repair Schwann cell and its function in regenerating nerves , 2016, The Journal of physiology.
[71] Jada Lewis. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.
[72] L. Greensmith,et al. c-Jun Reprograms Schwann Cells of Injured Nerves to Generate a Repair Cell Essential for Regeneration , 2012, Neuron.